Last Friday the Washington Post published an article about fake peer review and how it has affected the UK publisher BioMed Central. At least 43 papers have been retracted so far and we have not found this list to see if it included papers published in the Malaria Journal or Parasites & Vectors. How is it possible that such scandals emerge, one could wonder...
Bart G.J. Knols's blog
This week there is exciting news. We are jumping ahead of all publishers out there and have decided to do something unheard of in the world of scientfiic publishing: we will start to pay authors once their manuscripts have survived peer review and have been published online. We believe that your hard work should be rewarded rather than you paying Open Access publishers to have your article published online. Want to know how much you can earn? Read the story behind our decision by clicking here.
This week we published two new articles in the MalariaWorld Journal, so have a look. One deals with a highly interesting topic: how will people perceive and accept a malaria vaccine if it becomes available? The study was conducted in Nigeria. Second, a more basic study on deltorphin-II and its ability to impact on Plasmodium berghei. Go to 'MW Journal' and have a look (remember to log in to have full access (for free of course!).
This week also vital lessons learnt from the Blue Nile project that ran in Sudan. On how malaria can virtually be eliminated but can also return with horrible outcomes. Read Bill Jobin's story here.
Remember the call for you to participate in a survey that has been developed by Fredros Okumu of the Ifakara Health Institute in Tanzania. It is a survey that asks you to provide your views on how we can drive innovation in health, including malaria of course. It is a nice survey that will take you some 15 minutes to complete. Please note that the deadline for the initial survey is the 3rd of April. You can access the survey by clicking here.
Enjoy this week's MalariaWorld - the MW team (and we look forward to receiving your manuscripts!).
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at firstname.lastname@example.org
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, and you don’t pay to read. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.
The MalariaWorld Journal, now in its 6th volume, is the first truly Open Access journal with a focus on malaria. Where you don't pay to publish (authors) and you don't pay for access (readers). If you publish in the Malaria Journal, don't think its for free. You may not pay directly yourself, but your institutional library pays large sums of money for you to publish in that journal. True, they do give out waivers to developing country scientists, but at the end of the day it is all about money. And impact factors...
Last week the Roll Back Malaria Vector Control Working Group organised its 10th meeting in Geneva. Close to 200 vector control specialists from more than 30 countries attended the three-day event. What started as a small gathering years ago has grown to become what could be considered the equivalent of the annual ASTMH meeting but with an exclusive focus on vectors. And although this 10th meeting was ample reason for celebration, it wasn't. The meeting was officially addressed by WHO's Global Malaria Programme Director Dr. Pedro Alonso, who recently took office. His opening statements were clear: Insecticide resistance is as much a threat to continued successful malaria control, if not more, than the current Asian threat of artemisinin resistance. Pyrethroids were great and have undoubtedly saved many thousands of lives, but the era in which we could safely rely on them, is coming to an end. And that's bad news.
As of December 2014, MalariaWorld, the world's largest and only online scientific and social network for malaria professionals, is celebrating its 5th anniversary. It's been an adventure that we never imagined would become what it has become today. Many of you will not know the history of MalariaWorld, so here's a brief summary.
As a malaria professional you are supposed to keep track of what is happening in our field. That's nothing new. As scholars, researchers, policy makers, doctors, students, etc. we read about new developments, we read scientific articles, and follow the news. And in doing so we are familiar with who is doing what, follows what approach, and is seeking for new solutions to end our common enemy. Again, that is nothing new. But allow us to challenge you...